Author:
Schön Felix,Kieslich Aaron,Nebelung Heiner,Riediger Carina,Hoffmann Ralf-Thorsten,Zwanenburg Alex,Löck Steffen,Kühn Jens-Peter
Abstract
AbstractTo examine the comparative robustness of computed tomography (CT)-based conventional radiomics and deep-learning convolutional neural networks (CNN) to predict overall survival (OS) in HCC patients. Retrospectively, 114 HCC patients with pretherapeutic CT of the liver were randomized into a development (n = 85) and a validation (n = 29) cohort, including patients of all tumor stages and several applied therapies. In addition to clinical parameters, image annotations of the liver parenchyma and of tumor findings on CT were available. Cox-regression based on radiomics features and CNN models were established and combined with clinical parameters to predict OS. Model performance was assessed using the concordance index (C-index). Log-rank tests were used to test model-based patient stratification into high/low-risk groups. The clinical Cox-regression model achieved the best validation performance for OS (C-index [95% confidence interval (CI)] 0.74 [0.57–0.86]) with a significant difference between the risk groups (p = 0.03). In image analysis, the CNN models (lowest C-index [CI] 0.63 [0.39–0.83]; highest C-index [CI] 0.71 [0.49–0.88]) were superior to the corresponding radiomics models (lowest C-index [CI] 0.51 [0.30–0.73]; highest C-index [CI] 0.66 [0.48–0.79]). A significant risk stratification was not possible (p > 0.05). Under clinical conditions, CNN-algorithms demonstrate superior prognostic potential to predict OS in HCC patients compared to conventional radiomics approaches and could therefore provide important information in the clinical setting, especially when clinical data is limited.
Funder
Technische Universität Dresden
Publisher
Springer Science and Business Media LLC
Reference52 articles.
1. Altekruse, S. F., Devesa, S. S., Dickie, L. A., McGlynn, K. A. & Kleiner, D. E. Histological classification of liver and intrahepatic bile duct cancers in SEER registries. J. Regist. Manag. 38, 201–205 (2011).
2. Jemal, A. et al. Annual report to the nation on the status of cancer, 1975–2014 featuring survival. J. Natl. Cancer Inst. 109, djx030 (2017).
3. Reig, M. et al. BCLC strategy for prognosis prediction and treatment recommendation: The 2022 update. J. Hepatol. 76, 681–693 (2022).
4. Vitale, A. et al. Survival benefit of liver resection for patients with hepatocellular carcinoma across different Barcelona clinic liver cancer stages: A multicentre study. J. Hepatol. 62, 617–624 (2015).
5. Huitzil-Melendez, F.-D. et al. Advanced hepatocellular carcinoma: Which staging systems best predict prognosis?. J. Clin. Oncol. Off. J. Am. Soc. Clin. Oncol. 28, 2889–2895 (2010).
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献